You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.